Jefferies Boosts Price Target On Exact Sciences (EXAS) Following Q4, FDA Trial on Track
Go back to Jefferies Boosts Price Target On Exact Sciences (EXAS) Following Q4, FDA Trial on Track| Exact Sciences Corp (NASDAQ: EXAS) | Delayed: 104.91 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $104.91 | 52 Week High | $22.80 | |||
| Open | $104.91 | 52 Week Low | $4.67 | |||
| Day High | $104.91 | P/E | N/A | |||
| Day Low | $104.91 | EPS | $-0.69 | |||
| Volume | 180 | |||||
